MARIANA LOMBARDI PERES DE CARVALHO

Ms. MARIANA LOMBARDI PERES DE CARVALHO


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
NONatalia Quintella Sangiorgi Olivetti
Natalia Quintella Sangiorgi Olivetti
LSLuciana Sacilotto
Luciana Sacilotto
FWFanny Wulkan
Fanny Wulkan
GPGabrielle D'Arezzo Pessente
Gabrielle D'Arezzo Pessente
MCMARIANA LOMBARDI PERES DE CARVALHO
MARIANA LOMBARDI PERES DE CARVALHO
FDFrancisco Carlos da Costa Darrieux
Francisco Carlos da Costa Darrieux
Background:Arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disease, causes ventricular tachycardia, sudden cardiac death, and heart failure (HF). We investigated ARVC clinical features, genetic findings, natural history, and the occurrence of life-threatening arrhythmic events (LTAEs), HF death, or heart transplantation (HF-death/HTx) to identify risk factors. Methods:The clinical course of 111 consecutive patients with definite ARVC, predictors of LTAE, HF-death/HTx, and combined events were analyzed in the entire cohort and in a subgroup of 40 patients without sustained ventricular arrhythmia before diagnosis. Results:The 5-year cumulative probability of LTAE was 30% and HF-death/HTx was 10%. Predictors of HF-death/HTx were reduced right ventricle ejection fraction (HR: 0.93; P=0.010), HF symptoms (HR: 4.37; P=0.010), epsilon wave (HR: 4.99; P=0.015), and number of leads with low QRS voltage (HR: 1.28; P=0.001). Each additional lead with low QRS voltage increased the risk of HF-death/HTx by 28%. Predictors of LTAE were prior syncope (HR: 1.81; P=0.040), number of leads with T wave inversion (HR: 1.17; P=0.039), low QRS voltage (HR: 1.12; P=0.021), younger age (HR: 0.97; P=0.006), and prior ventricular arrhythmia/ventricular fibrillation (HR: 2.45; P=0.012). Each additional lead with low QRS voltage increased the risk of LTAE by 17%. In patients without ventricular arrhythmia before clinical diagnosis of ARVC, the number of leads with low QRS voltage (HR: 1.68; P=0.023) was independently associated with HF-death/HTx. Conclusions:Our study demonstrated the characteristics of a specific cohort with a high prevalence of arrhythmic burden at presentation, male predominance, younger age and HF severe outcomes. Our main results suggest that the presence and extension of low QRS voltage can be a risk predictor for HF-death/HTx in ARVC patients, regardless of the arrhythmic risk. This study can contribute to the global ARVC risk stratification, adding new insights to the international current scientific knowledge.

9 January 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
NONatalia Quintella Sangiorgi Olivetti
Natalia Quintella Sangiorgi Olivetti
LSLuciana Sacilotto
Luciana Sacilotto
DMDanilo Bora Moleta
Danilo Bora Moleta
LFLucas Arraes de França
Lucas Arraes de França
LCLorena Squassante Capeline
Lorena Squassante Capeline
FDFrancisco Carlos da Costa Darrieux
Francisco Carlos da Costa Darrieux
Introduction: The echocardiographic diagnosis criteria for arrhythmogenic right ventricular cardiomyopathy (ARVC) are highly specific but sensitivity is low, especially in the early stages of the disease. The role of echocardiographic strain in ARVC has not been fully elucidated, although prior studies suggest that it can improve the detection of subtle functional abnormalities. The purposes of the study were to determine whether these advanced measures of right ventricular (RV) dysfunction on echocardiogram, including RV strain, increase diagnostic value for ARVC disease detection and to evaluate the association of echocardiographic parameters with arrhythmic outcomes. Methods: The study included 28 patients from the Heart Institute of São Paulo ARVC cohort with a definite diagnosis of ARVC established according to the 2010 Task Force Criteria. All patients were submitted to ECHO’s advanced techniques including RV strain, and the parameters were compared to prior conventional visual ECHO and CMR. Results: In total, 28 patients were enrolled in order to perform ECHO’s advanced techniques. A total of 2/28 (7%) patients died due to a cardiovascular cause, 2/28 (7%) underwent heart transplantation, and 14/28 (50%) patients developed sustained ventricular arrhythmic events. Among ECHO’s parameters, RV dilatation, measured by RVDd (p = 0.018) and RVOT PSAX (p = 0.044), was significantly associated with arrhythmic outcomes. RV free wall longitudinal strain < 14.35% in absolute value was associated with arrhythmic outcomes (p = 0.033). Conclusion: Our data suggest that ECHO’s advanced techniques improve ARVC detection and that abnormal RV strain can be associated with arrhythmic risk stratification. Further studies are necessary to better demonstrate these findings and contribute to risk stratification in ARVC, in addition to other well-known risk markers.

4 May 2022 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
EPEduardo Nolla Silva Pereira
Eduardo Nolla Silva Pereira
LSLuciana Sacilotto
Luciana Sacilotto
GPGabrielle D'Arezzo Pessente
Gabrielle D'Arezzo Pessente
CGCinthya Guirao
Cinthya Guirao
MCMARIANA LOMBARDI PERES DE CARVALHO
MARIANA LOMBARDI PERES DE CARVALHO
MSMaurício Ibrahim Scanavacca
Maurício Ibrahim Scanavacca
Introdução A síndrome do QT longo tipo 3 (SQTL3) é uma canalopatia de alta letalidade. Está associada ao déficit de fechamento dos canais tardios de sódio, decorrentes de mutações no gene SCN5A , de padrão autossômico dominante, responsável por 7-10% de todas as síndromes do QT longo (SQTL). A apresentação inicial pode ter amplo espectro, desde assintomáticos, até morte súbita no primeiro ano de vida. A adição do bloqueador do canal de sódio classe IB (mexiletina) ao propranolol ou nadolol [...] Introdução A síndrome do QT longo tipo 3 (SQTL3) é uma canalopatia de alta letalidade. Está associada ao déficit de fechamento dos canais tardios de sódio, decorrentes de mutações no gene SCN5A , de padrão autossômico dominante, responsável por 7-10% de todas as síndromes do QT longo (SQTL). A apresentação inicial pode ter amplo espectro, desde assintomáticos, até morte súbita no primeiro ano de vida. A adição do bloqueador do canal de sódio classe IB (mexiletina) ao propranolol ou nadolol

1 May 2025 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Open access
PDF file
NONatalia Quintella Sangiorgi Olivetti
Natalia Quintella Sangiorgi Olivetti
MPMárya Pagotti
Márya Pagotti
BSBruno Moreira Santos
Bruno Moreira Santos
MMMarjorie Mizuta
Marjorie Mizuta
BLBianca Linnenkamp
Bianca Linnenkamp
JKJose Krieger
Jose Krieger
Filamin C (FLNC) plays a critical role in maintaining the structural integrity of muscle cells, particularly within the cardiac sarcomere. Pathogenic variants in the FLNC gene are increasingly recognized as significant contributors to a diverse range of cardiomyopathies, including dilated (DCM), hypertrophic (HCM), arrhythmogenic (ACM), and restrictive cardiomyopathy (RCM). This review explores the genotype-phenotype correlations in FLNC-related cardiomyopathies, emphasizing how the type and location of genetic variants influence the clinical presentation. Truncating variants are primarily associated with DCM and [...] Abstract Filamin C (FLNC) plays a critical role in maintaining the structural integrity of muscle cells, particularly within the cardiac sarcomere. Pathogenic variants in the FLNC gene are increasingly recognized as significant contributors to a diverse range of cardiomyopathies, including dilated (DCM), hypertrophic (HCM), arrhythmogenic (ACM), and restrictive cardiomyopathy (RCM). This review explores the genotype-phenotype correlations in FLNC-related cardiomyopathies, emphasizing how the type and location of genetic variants influence the clinical presentation. Truncating variants are primarily associated with DCM and

1 March 2025 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
PDF file
SFSilas Ramos Furquim
Silas Ramos Furquim
LPLucas Vieira Lacerda Pires
Lucas Vieira Lacerda Pires
NBNara Alves Buriti
Nara Alves Buriti
MCMARIANA LOMBARDI PERES DE CARVALHO
MARIANA LOMBARDI PERES DE CARVALHO
EMEmanuelle Leonilia Marques
Emanuelle Leonilia Marques
JKJosé Eduardo Krieger
José Eduardo Krieger
A case of a 54-year-old man who underwent a heart transplant with early asymmetric hypertrophy unrelated to rejection. Donor’s genetic analysis revealed a variant in folliculin gene, associated with Birt-Hogg-Dubé Syndrome. Screening of the donor’s family uncovered a similar hypertrophy and same genetic variant in the donor’s father. Although genetic evaluation of donors’ tissues is not routine, it can be crucial for understanding changes unrelated to the transplant procedure and identifying carriers of pathogenic variants.

2 October 2026 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
NONatalia Quintella Sangiorgi Olivetti
Natalia Quintella Sangiorgi Olivetti
LSLuciana Sacilotto
Luciana Sacilotto
JFJulia de Barros Negri Ferreira
Julia de Barros Negri Ferreira
SFSilas Furquim
Silas Furquim
MPMárya Pagotti
Márya Pagotti
JKJose Krieger
Jose Krieger
BACKGROUND: Pathogenic and likely pathogenic variants in filamin C ( FLNC ) cause a broad spectrum of cardiomyopathies. However, available genotype-phenotype data are derived predominantly from European and North American populations, with limited representation of admixed populations. METHODS: We characterized carriers of pathogenic/likely pathogenic FLNC variants identified among 2654 unrelated probands undergoing exome sequencing for suspected inherited cardiomyopathy and their relatives identified through cascade screening. Clinical, electrocardiographic, imaging, genetic, and longitudinal data were analyzed according to cardiomyopathy phenotype and variant class. Genetic ancestry was evaluated. Associations with arrhythmic, heart failure, and composite outcomes were examined in exploratory analyses. RESULTS: The cohort included 97 carriers (58 probands, 39 relatives), of whom 72 had cardiomyopathy and 25 were phenotype-negative at evaluation. Truncating variants predominated among patients with arrhythmogenic cardiomyopathy and dilated cardiomyopathy, whereas missense variants were concentrated among those with hypertrophic cardiomyopathy and restrictive cardiomyopathy. Arrhythmogenic cardiomyopathy and dilated cardiomyopathy were characterized by a greater burden of ventricular arrhythmias, low QRS voltage, systolic dysfunction, and myocardial fibrosis, whereas hypertrophic cardiomyopathy and restrictive cardiomyopathy showed greater wall thickness and more atrial arrhythmias. Twelve pathogenic/likely pathogenic variants absent from gnomAD and ClinVar were identified. Ancestry analysis confirmed heterogeneous genetic backgrounds but detected no ancestry-related differences in variant class or phenotype. In exploratory outcome analyses, nonsustained ventricular tachycardia, low QRS voltage, and late gadolinium enhancement were associated with outcomes. CONCLUSIONS: This deeply phenotyped Brazilian cohort expands the FLNC variant spectrum and supports broad genotype-phenotype associations across an admixed population. Exploratory findings suggest that markers of ventricular arrhythmia and myocardial fibrosis may complement left ventricular ejection fraction in future risk-stratification strategies, although validation in larger, independent cohorts is required.